List of Tables
Table 1. Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Equine Pharmaceuticals and Supplements Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Equine Pharmaceuticals and Supplements Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Equine Pharmaceuticals and Supplements Sales by Region (2020-2025) & (K Units)
Table 5. Global Equine Pharmaceuticals and Supplements Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Equine Pharmaceuticals and Supplements Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Equine Pharmaceuticals and Supplements Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Equine Pharmaceuticals and Supplements Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Equine Pharmaceuticals and Supplements Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Equine Pharmaceuticals and Supplements Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Equine Pharmaceuticals and Supplements Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Equine Pharmaceuticals and Supplements Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Equine Pharmaceuticals and Supplements Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Equine Pharmaceuticals and Supplements Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Equine Pharmaceuticals and Supplements Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Equine Pharmaceuticals and Supplements Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Equine Pharmaceuticals and Supplements Sales Share by Manufacturer (2020-2025)
Table 18. Equine Pharmaceuticals and Supplements Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Equine Pharmaceuticals and Supplements Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Equine Pharmaceuticals and Supplements Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Equine Pharmaceuticals and Supplements Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Equine Pharmaceuticals and Supplements Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Equine Pharmaceuticals and Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Pharmaceuticals and Supplements as of 2024)
Table 24. Equine Pharmaceuticals and Supplements Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Equine Pharmaceuticals and Supplements Market
Table 26. Manufacturers Equine Pharmaceuticals and Supplements Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Boehringer Ingelheim Company Information
Table 29. Boehringer Ingelheim Description and Business Overview
Table 30. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product
Table 31. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Boehringer Ingelheim Sales Proportion of Equine Pharmaceuticals and Supplements by Product in 2024
Table 33. Boehringer Ingelheim Sales Proportion of Equine Pharmaceuticals and Supplements by Application in 2024
Table 34. Boehringer Ingelheim Sales Proportion of Equine Pharmaceuticals and Supplements by Geographic Area in 2024
Table 35. Boehringer Ingelheim Recent Developments
Table 36. Merck Animal Health Company Information
Table 37. Merck Animal Health Description and Business Overview
Table 38. Merck Animal Health Equine Pharmaceuticals and Supplements Product
Table 39. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Merck Animal Health Sales Proportion of Equine Pharmaceuticals and Supplements by Product in 2024
Table 41. Merck Animal Health Sales Proportion of Equine Pharmaceuticals and Supplements by Application in 2024
Table 42. Merck Animal Health Sales Proportion of Equine Pharmaceuticals and Supplements by Geographic Area in 2024
Table 43. Merck Animal Health Recent Developments
Table 44. Zoetis Company Information
Table 45. Zoetis Description and Business Overview
Table 46. Zoetis Equine Pharmaceuticals and Supplements Product
Table 47. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Zoetis Sales Proportion of Equine Pharmaceuticals and Supplements by Product in 2024
Table 49. Zoetis Sales Proportion of Equine Pharmaceuticals and Supplements by Application in 2024
Table 50. Zoetis Sales Proportion of Equine Pharmaceuticals and Supplements by Geographic Area in 2024
Table 51. Zoetis Recent Developments
Table 52. Bayer Animal Health Company Information
Table 53. Bayer Animal Health Description and Business Overview
Table 54. Bayer Animal Health Equine Pharmaceuticals and Supplements Product
Table 55. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Bayer Animal Health Sales Proportion of Equine Pharmaceuticals and Supplements by Product in 2024
Table 57. Bayer Animal Health Sales Proportion of Equine Pharmaceuticals and Supplements by Application in 2024
Table 58. Bayer Animal Health Sales Proportion of Equine Pharmaceuticals and Supplements by Geographic Area in 2024
Table 59. Bayer Animal Health Recent Developments
Table 60. Elanco Animal Health Company Information
Table 61. Elanco Animal Health Description and Business Overview
Table 62. Elanco Animal Health Equine Pharmaceuticals and Supplements Product
Table 63. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Elanco Animal Health Sales Proportion of Equine Pharmaceuticals and Supplements by Product in 2024
Table 65. Elanco Animal Health Sales Proportion of Equine Pharmaceuticals and Supplements by Application in 2024
Table 66. Elanco Animal Health Sales Proportion of Equine Pharmaceuticals and Supplements by Geographic Area in 2024
Table 67. Elanco Animal Health Recent Developments
Table 68. Dechra Veterinary Products Company Information
Table 69. Dechra Veterinary Products Description and Business Overview
Table 70. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product
Table 71. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Dechra Veterinary Products Sales Proportion of Equine Pharmaceuticals and Supplements by Product in 2024
Table 73. Dechra Veterinary Products Sales Proportion of Equine Pharmaceuticals and Supplements by Application in 2024
Table 74. Dechra Veterinary Products Sales Proportion of Equine Pharmaceuticals and Supplements by Geographic Area in 2024
Table 75. Dechra Veterinary Products Recent Developments
Table 76. CEVA Company Information
Table 77. CEVA Description and Business Overview
Table 78. CEVA Equine Pharmaceuticals and Supplements Product
Table 79. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. CEVA Sales Proportion of Equine Pharmaceuticals and Supplements by Product in 2024
Table 81. CEVA Sales Proportion of Equine Pharmaceuticals and Supplements by Application in 2024
Table 82. CEVA Sales Proportion of Equine Pharmaceuticals and Supplements by Geographic Area in 2024
Table 83. CEVA Recent Developments
Table 84. Virbac Company Information
Table 85. Virbac Description and Business Overview
Table 86. Virbac Equine Pharmaceuticals and Supplements Product
Table 87. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Virbac Sales Proportion of Equine Pharmaceuticals and Supplements by Product in 2024
Table 89. Virbac Sales Proportion of Equine Pharmaceuticals and Supplements by Application in 2024
Table 90. Virbac Sales Proportion of Equine Pharmaceuticals and Supplements by Geographic Area in 2024
Table 91. Virbac Recent Developments
Table 92. Norbrook Equine Company Information
Table 93. Norbrook Equine Description and Business Overview
Table 94. Norbrook Equine Equine Pharmaceuticals and Supplements Product
Table 95. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Norbrook Equine Sales Proportion of Equine Pharmaceuticals and Supplements by Product in 2024
Table 97. Norbrook Equine Sales Proportion of Equine Pharmaceuticals and Supplements by Application in 2024
Table 98. Norbrook Equine Sales Proportion of Equine Pharmaceuticals and Supplements by Geographic Area in 2024
Table 99. Norbrook Equine Recent Developments
Table 100. Kyoritsu Seiyaku Company Information
Table 101. Kyoritsu Seiyaku Description and Business Overview
Table 102. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product
Table 103. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Kyoritsu Seiyaku Sales Proportion of Equine Pharmaceuticals and Supplements by Product in 2024
Table 105. Kyoritsu Seiyaku Sales Proportion of Equine Pharmaceuticals and Supplements by Application in 2024
Table 106. Kyoritsu Seiyaku Sales Proportion of Equine Pharmaceuticals and Supplements by Geographic Area in 2024
Table 107. Kyoritsu Seiyaku Recent Developments
Table 108. Vetoquinol Company Information
Table 109. Vetoquinol Description and Business Overview
Table 110. Vetoquinol Equine Pharmaceuticals and Supplements Product
Table 111. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Vetoquinol Sales Proportion of Equine Pharmaceuticals and Supplements by Product in 2024
Table 113. Vetoquinol Sales Proportion of Equine Pharmaceuticals and Supplements by Application in 2024
Table 114. Vetoquinol Sales Proportion of Equine Pharmaceuticals and Supplements by Geographic Area in 2024
Table 115. Vetoquinol Recent Developments
Table 116. Protexin Healthcare Company Information
Table 117. Protexin Healthcare Description and Business Overview
Table 118. Protexin Healthcare Equine Pharmaceuticals and Supplements Product
Table 119. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Protexin Healthcare Sales Proportion of Equine Pharmaceuticals and Supplements by Product in 2024
Table 121. Protexin Healthcare Sales Proportion of Equine Pharmaceuticals and Supplements by Application in 2024
Table 122. Protexin Healthcare Sales Proportion of Equine Pharmaceuticals and Supplements by Geographic Area in 2024
Table 123. Protexin Healthcare Recent Developments
Table 124. Audevard Company Information
Table 125. Audevard Description and Business Overview
Table 126. Audevard Equine Pharmaceuticals and Supplements Product
Table 127. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Audevard Sales Proportion of Equine Pharmaceuticals and Supplements by Product in 2024
Table 129. Audevard Sales Proportion of Equine Pharmaceuticals and Supplements by Application in 2024
Table 130. Audevard Sales Proportion of Equine Pharmaceuticals and Supplements by Geographic Area in 2024
Table 131. Audevard Recent Developments
Table 132. Ouro Fino Saude Company Information
Table 133. Ouro Fino Saude Description and Business Overview
Table 134. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product
Table 135. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Ouro Fino Saude Sales Proportion of Equine Pharmaceuticals and Supplements by Product in 2024
Table 137. Ouro Fino Saude Sales Proportion of Equine Pharmaceuticals and Supplements by Application in 2024
Table 138. Ouro Fino Saude Sales Proportion of Equine Pharmaceuticals and Supplements by Geographic Area in 2024
Table 139. Ouro Fino Saude Recent Developments
Table 140. North America Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K Units)
Table 141. North America Equine Pharmaceuticals and Supplements Sales by Country (2026-2031) & (K Units)
Table 142. North America Equine Pharmaceuticals and Supplements Revenue by Country (2020-2025) & (US$ Million)
Table 143. North America Equine Pharmaceuticals and Supplements Revenue by Country (2026-2031) & (US$ Million)
Table 144. North America Equine Pharmaceuticals and Supplements Sales by Type (2020-2025) & (K Units)
Table 145. North America Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Units)
Table 146. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Region (2020-2025) & (K Units)
Table 147. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Region (2026-2031) & (K Units)
Table 148. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2020-2025) & (US$ Million)
Table 149. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2026-2031) & (US$ Million)
Table 150. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Type (2020-2025) & (K Units)
Table 151. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Units)
Table 152. Europe Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K Units)
Table 153. Europe Equine Pharmaceuticals and Supplements Sales by Country (2026-2031) & (K Units)
Table 154. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2020-2025) & (US$ Million)
Table 155. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2026-2031) & (US$ Million)
Table 156. Europe Equine Pharmaceuticals and Supplements Sales by Type (2020-2025) & (K Units)
Table 157. Europe Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Units)
Table 158. Latin America Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K Units)
Table 159. Latin America Equine Pharmaceuticals and Supplements Sales by Country (2026-2031) & (K Units)
Table 160. Latin America Equine Pharmaceuticals and Supplements Revenue by Country (2020-2025) & (US$ Million)
Table 161. Latin America Equine Pharmaceuticals and Supplements Revenue by Country (2026-2031) & (US$ Million)
Table 162. Latin America Equine Pharmaceuticals and Supplements Sales by Type (2020-2025) & (K Units)
Table 163. Latin America Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Units)
Table 164. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K Units)
Table 165. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2026-2031) & (K Units)
Table 166. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2020-2025) & (US$ Million)
Table 167. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2026-2031) & (US$ Million)
Table 168. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Type (2020-2025) & (K Units)
Table 169. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Application (2020-2025) & (K Units)
Table 170. Equine Pharmaceuticals and Supplements Key Raw Materials, Industry Status and Trend
Table 171. Equine Pharmaceuticals and Supplements Key Raw Materials and Upstream Suppliers
Table 172. Equine Pharmaceuticals and Supplements Clients Status and Trend
Table 173. Equine Pharmaceuticals and Supplements Typical Clients
Table 174. Equine Pharmaceuticals and Supplements Distributors
Table 175. Equine Pharmaceuticals and Supplements Market Trends
Table 176. Equine Pharmaceuticals and Supplements Market Drivers
Table 177. Equine Pharmaceuticals and Supplements Market Challenges
Table 178. Equine Pharmaceuticals and Supplements Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
Table 182. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Equine Pharmaceuticals and Supplements Product Picture
Figure 2. Global Equine Pharmaceuticals and Supplements Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2024 & 2031
Figure 4. Pharmaceuticals Product Picture
Figure 5. Supplements Product Picture
Figure 6. Global Equine Pharmaceuticals and Supplements Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2024 & 2031
Figure 8. Thoroughbred Horse
Figure 9. Other Types of Horses
Figure 10. Equine Pharmaceuticals and Supplements Report Years Considered
Figure 11. Global Equine Pharmaceuticals and Supplements Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Equine Pharmaceuticals and Supplements Market Size 2020-2031 (US$ Million)
Figure 13. Global Equine Pharmaceuticals and Supplements Sales 2020-2031 (K Units)
Figure 14. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2020-2031)
Figure 16. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global Equine Pharmaceuticals and Supplements Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Equine Pharmaceuticals and Supplements Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 19. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global Equine Pharmaceuticals and Supplements Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Equine Pharmaceuticals and Supplements Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 22. Pharmaceuticals of Equine Pharmaceuticals and Supplements Revenue Market Share by Application, 2024 VS 2031
Figure 23. Supplements of Equine Pharmaceuticals and Supplements Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global Equine Pharmaceuticals and Supplements Sales Share by Manufacturer in 2024
Figure 25. Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Pharmaceuticals Market Sales Proportion by Manufacturer in 2024
Figure 27. Supplements Market Sales Proportion by Manufacturer in 2024
Figure 28. North America Equine Pharmaceuticals and Supplements Revenue 2020-2031 (US$ Million)
Figure 29. North America Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2025)
Figure 30. North America Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2025)
Figure 36. Europe Equine Pharmaceuticals and Supplements Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country (2020-2031)
Figure 38. Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2020-2031)
Figure 39. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2025)
Figure 40. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2025)
Figure 41. Latin America Equine Pharmaceuticals and Supplements Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Equine Pharmaceuticals and Supplements Sales Market Share by Country (2020-2031)
Figure 43. Latin America Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2020-2025)
Figure 44. Latin America Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2025)
Figure 45. Latin America Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2025)
Figure 51. Equine Pharmaceuticals and Supplements Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Equine Pharmaceuticals and Supplements Raw Materials by Region in 2024
Figure 53. Equine Pharmaceuticals and Supplements Distribution Channels
Figure 54. Global Equine Pharmaceuticals and Supplements Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Equine Pharmaceuticals and Supplements Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
